New Drugs, Post-Covid Syndrome, Headaches, Infectious Disease

Recorded November 16, 2023. This course is course is valid until November 16, 2026 and may be taken for credit up to that time.

• TOPIC 1: New Drug Update 2023: What’s Hot and What’s Not Part 2:

  • Identify new primary care medications approved in 2022-23.

  • 3.Discuss the use, side effects, drug-drug interactions, and benefits of each of the medications.

  • 4.Discuss updates related to labeling, indications, risks associated with various medications.

• TOPIC 2: Outpatient Protocols for Post- COVID (Long-COVID) Syndrome: Acute Management and Long-Term Surveillance:

  • 6.Review diagnostic criteria for Post-Covid Syndrome.

  • 7.Identify symptoms associated with Post-Covid Syndrome.

  • 8.Discuss treatment options for the patient with post-covid syndrome.

• TOPIC 3: Pharmacotherapeutic Management of Headaches in Primary and Urgent Care

  • 10.Discuss current research regarding the etiology of primary and secondary headaches and impact of medications on each type of headache.

  • 11.Identify the signs and symptoms of primary and secondary headaches.

  • 12.Discuss the various pharmacologic and non-pharmacologic treatments available for individuals with primary headaches.

• TOPIC 4: Emerging Infectious Disease Update (Part 1):

  • Discuss various viral and bacterial infectious diseases ( lyme, Influenza.)

  • Identify the most common tests to identify etiology of various infectious diseases .

  • Discuss treatment options for various emerging viral and bacterial infections.

    ACCREDITATION

• University Learning Systems is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education.

• California Board of Registered Nursing Provider No. CEP 11409, for 5 contact hours (0.5 CEU).

• CE Broker Tracking #: 50-11357

PRINCIPAL AUDIENCE

PHARMACISTS: University Learning Systems reports credit to CPE Monitor. This course provides 5 contact hours (0.5 CEU). Part 1: 0741-0000-23-025-H01-P

ACTIVITY: APPLICATION. No Partial credit is awarded. This course is course is valid until December 7, 2026 and may be taken for credit up to that time.

CANADIAN PHARMACISTS: Canadian Council on Continuing Education in Pharmacy (CCCEP) accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE).

NURSE PRACTITIONERS/NURSES: This course provides 5 contact hours (0.5 CEU) of pharmacotherapeutics / pharmacology requirements for American Nurses Credentialing Center (ANCC) Category 1 Continuing Education Hours. The same hours submitted to renew certification may be submitted to a State Board of Nursing for re-licensure. American Nurses Credentialing Center (ANCC) accepts formally approved continuing education sponsored by organizations accredited or approved by the Accreditation Council for Pharmacy Education (ACPE).

OTHER HEALTH PROFESSIONALS: Please contact your respective board.

PHYSICIANS: This course may be considered for AMA Category 2 credit only.

CANADIAN PHYSICIANS: This course may be considered for AMA Category 2 credit only which may be equivalent to MAINPRO-M2 credits. Please contact your respective board.

PHYSICIAN ASSISTANTS: This course may be considered for AMA Category 2 credit only.